Attleboro, Massachusetts Clinical Trials

A listing of Attleboro, Massachusetts clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 7 clinical trials
Mifepristone for the Prevention of Relapses of Alcohol Drinking

The goal of this study is to determine if, under stress, alcohol drinking is reduced using mifepristone

Center for Alcohol and Addiction Studies, Brown University
 (8.8 away) Contact site
  • 4 views
  • 29 Dec, 2019
  • 1 location
Impact of Nicotine Reduction on Adolescent Cigarette Use Alternative Tobacco Use and Harm From Tobacco

Adolescents are an important vulnerable population to consider as the FDA moves toward a nicotine reduction policy. Such a policy, which would mandate a reduction of nicotine in all commercially available cigarettes, has the potential to transform public health and greatly reduce the toll of tobacco-related death and disease. Yet, …

Brown University School of Public Health
 (8.8 away) Contact site
  • 6 views
  • 26 Jan, 2020
  • 1 location
Safety Tolerability and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult Patients With COVID-19

The primary objectives are: Phase 1 To evaluate the safety and tolerability of REGN10933+REGN10987 compared to placebo To evaluate the virologic efficacy of REGN10933+REGN10987 compared to placebo in reducing viral shedding of SARS-CoV-2 Phase 2 To evaluate the virologic efficacy of REGN10933+REGN10987 compared to placebo in reducing viral shedding of …

molecular diagnostic
viral shedding
covid-19
SARS
oropharyngeal
Regeneron Study Site
 (9.6 away) Contact site
  • 4049 views
  • 18 Nov, 2020
  • +81 other locations
Safety Tolerability and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19

The primary objectives are: Phase 1 To evaluate the safety and tolerability of REGN10933+REGN10987 compared to placebo To evaluate the virologic efficacy of REGN10933+REGN10987 compared to placebo in reducing viral shedding of SARS-CoV-2 Phase 2 To evaluate the virologic efficacy of REGN10933+REGN10987 compared to placebo in reducing viral shedding of …

molecular diagnostic
viral shedding
covid-19
SARS
oximetry
Regeneron Study Site
 (7.6 away) Contact site
  • 1779 views
  • 20 Nov, 2020
  • +90 other locations
9-ING-41 in Patients With Advanced Cancers

GSK-3 is a potentially important therapeutic target in human malignancies. The Actuate 1801 Phase 1/2 study is designed to evaluate the safety and efficacy of 9-ING-41, a potent GSK-3 inhibitor, as a single agent and in combination with cytotoxic agents, in patients with refractory cancers.

bone marrow procedure
corticosteroids
general anesthesia
kidney function tests
measurable disease
Rhode Island Hospital
 (9.6 away) Contact site
  • 542 views
  • 12 Oct, 2020
  • +13 other locations
An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors

The purpose of the dose escalation part of this study is to determine the feasibility of using the combination of copanlisib and nivolumab in subjects with advanced solid tumors, and to determine the maximum tolerated dose of copanlisib in combination with nivolumab. The maximum tolerated dose will then be used …

cancer chemotherapy
EGFR
epidermal growth factor receptor
growth factor
nivolumab
Rhode Island Hospital
 (9.6 away) Contact site
  • 34 views
  • 22 Nov, 2020
  • +11 other locations
Dose Escalation of DF6002 in Patients With Advanced Solid Tumors and Expansion in Selected Indications

This study is a Phase 1/2, open-label, dose-escalation study with a consecutive parallel-group efficacy expansion study, designed to determine the safety, tolerability, PK, pharmacodynamics, and preliminary anti-tumor activity of DF6002 as monotherapy and in combination with nivolumab.

transitional cell carcinoma
lung cancer
advanced urothelial carcinoma
braf inhibitor
platinum-based chemotherapy
Rhode Island Hospital
 (9.6 away) Contact site
  • 12 views
  • 07 Oct, 2020
  • +2 other locations